Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 4

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03411499Not ApplicableTerminated

Stroke-free Survival Comparison Between Early Surgery and Conventional Therapy in Left Infective Endocarditis

Role: lead

NCT02571868Completed

Acute and Cronic Evaluation of AV/PV and VV Delay IEGM Based Optimisation Algorithm-QuickSept Study

Role: lead

NCT02400983Completed

Real Life Automatic Atrial Capture Device Control

Role: lead

NCT01552187Phase 3Unknown

COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)

Role: lead

NCT01923038Not ApplicableCompleted

Evaluation of Ventilatory Strategies During Laparoscopic Surgery

Role: lead

NCT01910779Not ApplicableUnknown

Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks

Role: lead

NCT01906749Phase 4Unknown

Colchicine for Acute Coronary Syndromes

Role: lead

NCT01665495Not ApplicableUnknown

Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention

Role: lead

All 8 trials loaded